The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Arcutis Biotherapeutics Inc’s current trading price is -16.68% away from its 52-week high, while its distance from the 52-week low is 84.18%. The stock’s price range for this period has been between $8.03 and $17.75 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.37 million for the day, a number notably higher than the average daily volume of 1.86 million over the last three months.
The stock price for Arcutis Biotherapeutics Inc (ARQT) currently stands at $14.79. The stock experienced a substantial increase in the last session, hitting $23.0 after starting at $14.63. The stock’s lowest price was $18.0 before closing at $15.36.
Arcutis Biotherapeutics Inc’s market performance has been stable in recent times.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Arcutis Biotherapeutics Inc (ARQT) has experienced a quarterly rise of 7.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.76B and boasts a workforce of 342 employees.
Arcutis Biotherapeutics Inc: What Analysts Are Saying
As of right now, 3 analysts are rating Arcutis Biotherapeutics Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ARQT stands at 0.79. Similarly, the long-term debt-to-equity ratio is also 0.79.
ARQT Stock Stochastic Average
Arcutis Biotherapeutics Inc’s raw stochastic average for the past 50 days is presently 49.13%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 17.81%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 9.75% and 10.00%, respectively.
ARQT Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 62.62%. However, over the past six months, we’ve seen a weaker performance of 12.22%. The price of ARQT fallen by 4.01% over the last 30 days. And in the last five days, it has surged by 1.44%.
